Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,071 | 0,073 | 15:13 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Minutes of IMPLANET's Ordinary General Meeting held on April 25, 2024 | 168 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants for orthopedic surgery... ► Artikel lesen | |
09.04. | IMPLANET reports Q1 revenue of €2.2M | 1 | Seeking Alpha | ||
09.04. | IMPLANET Reports its 2024 First-Quarter Revenue | 162 | Business Wire | +10% growth in the French market vs. 2023 Q1
Continued expansion of the SMTP surgical equipment distribution activity
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168... ► Artikel lesen | |
06.03. | Implanet S.A. SPON ADS EACH REPR 0.05 ORD SHS reports FY results | 1 | Seeking Alpha | ||
06.03. | IMPLANET Reports Its 2023 Full-Year Results | 206 | Business Wire | Governance evolution in line with the agreement with Sanyou Medical
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plan), a medical technology... ► Artikel lesen | |
02.02. | Implanet Announces the Success of Its Capital Increase | 389 | Business Wire | BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), (the "Company"), a medical technology... ► Artikel lesen | |
25.01. | Implanet Announces the Appointment of Max W. Painter as Vice-President and General Manager of its US Subsidiary | 394 | Business Wire | Over 25 years of experience in innovative medical technologies with world leaders in spine surgery Strong expertise in strategic and commercial management
Regulatory News:
IMPLANET... ► Artikel lesen | |
16.01. | Implanet reports Q4 revenue decline of 20% Y/Y | 1 | Seeking Alpha | ||
15.01. | IMPLANET Reports 2023 Annual Revenue of €7.4 Million | 372 | Business Wire | BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company... ► Artikel lesen | |
12.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 12.01.2024 | 382 | Xetra Newsboard | Das Instrument 8040 SE0020354389 ZAPLOX AB EQUITY wird cum Kapitalmassnahme gehandelt am 12.01.2024 und ex Kapitalmassnahme am 15.01.2024 The instrument 8040 SE0020354389 ZAPLOX AB EQUITY is traded... ► Artikel lesen | |
11.01. | IMPLANET Announces Its 2024 Financial Calendar | 289 | Business Wire | Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the... ► Artikel lesen | |
04.01. | IMPLANET: Launch of an issue of new shares with preferential subscription rights | 592 | Business Wire | Fundraising of €6.38 million with preferential subscription rights, through the issue of New Shares with a ratio of 19 New Shares for 8 preferential subscription rights (which may be increased... ► Artikel lesen | |
12.12.23 | IMPLANET Announces the Launch of Its Training Program in Advance of Marketing its JAZZ Range in China | 316 | Business Wire | First Chinese surgeon participation in IMPLANET's JAZZ Academy
Registration of the JAZZ range with the Chinese health authorities is ongoing
Regulatory News:
IMPLANET (Euronext Growth:... ► Artikel lesen | |
11.12.23 | Validation by Sanyou Medical's Board of Directors of Its Commitment to Subscribe up to €5 Million to IMPLANET's Planned Capital Increase | 272 | Business Wire | The planned capital increase remains subject to the approval of the relevant Chinese government authorities, expected in January 2024
Drawdown by IMPLANET of the balance of the bond issue... ► Artikel lesen | |
16.11.23 | IMPLANET Receives the Approval of Its Shareholders for Its Planned Capital Increase | 348 | Business Wire | Adoption of resolutions at today's Extraordinary General Meeting concerning the capital increase to take place in January 2024
Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168... ► Artikel lesen | |
31.10.23 | IMPLANET plans €5.5m-€6.6m capital raise with shareholder rights issue | 2 | Investing.com | ||
31.10.23 | IMPLANET Specifies the Terms of Its Planned Capital Increase | 274 | Business Wire | Details regarding the terms for setting the price of the planned capital increase of between €5.5M and €6.4M to take place in January 2024, to be submitted to a vote at the Annuel General Meeting... ► Artikel lesen | |
17.10.23 | IMPLANET Announces Its 3Rd-quarter and 9-Month Revenue to September 30, 2023 | 312 | Business Wire | Proposed capital increase with preferential subscription rights to be carried out in January 2024 and put to a vote at an Extraordinary General Meeting to be held on November 16, 2023
Regulatory... ► Artikel lesen | |
11.10.23 | IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue | 402 | Business Wire | Extraordinary General Meeting called to approve the capital increase planned for January 2024
Drawdown of the first tranche of the bond issue representing 50% of the maximum total financing... ► Artikel lesen | |
28.09.23 | IMPLANET Signs an Agreement With Sanyou Medical for a Proposed Capital Increase With Preferential Subscription Rights | 385 | Business Wire | Proposed capital increase with preferential subscription rights, to be carried out in January 2024 to strengthen IMPLANET's equity capital and enable business development, subject to a vote at... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INVITAE | 0,110 | 0,00 % | Labcorp Wins Bid To Acquire Invitae Assets For $239 Mln Plus Non-Cash Considerations | WASHINGTON (dpa-AFX) - Invitae said that Labcorp (LH) has emerged as the successful bidder in the company's auction during its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 52,28 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
SIEMENS HEALTHINEERS | 52,58 | +0,54 % | DAX-Check LIVE: Adidas, Commerzbank, Infineon, Rheinmetall, Sartorius, Siemens Healthineers im Fokus | Dem DAX gelang es gestern nicht eine klare Richtung zu finden. Am Ende des Tages zog er dann aber doch etwas an und ging mit einem Zugewinn von 0,38 Prozent aus dem Handel. Worauf es jetzt für den DAX... ► Artikel lesen | |
FRESENIUS | 27,120 | -0,22 % | Fresenius und FMC: Aktien im Aufwind - das beflügelt | Die Aktien von Fresenius und ihrer ehemaligen Tochtergesellschaft Fresenius Medical Care (FMC) zeigen am Montag eine robuste Performance. Die Fresenius-Aktie erreichte zwischenzeitlich den höchsten... ► Artikel lesen | |
PROGYNY | 32,500 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
RXSIGHT | 51,89 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
PRIVIA HEALTH GROUP | 17,990 | 0,00 % | Where Privia Health Gr Stands With Analysts | ||
MIMEDX | 6,245 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 23,780 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,750 | -0,11 % | Fresenius Medical Care mit SONDERMELDUNG: Könnte die Aktie JETZT komplett drehen - Dringend vor dem Wochenende handeln! | ||
CARL ZEISS MEDITEC | 99,80 | +0,81 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
IMAC HOLDINGS | 5,100 | 0,00 % | (BACK) - Analyzing IMAC Holdings' Short Interest | ||
ATRICURE | 22,610 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
ADAPTHEALTH | 9,580 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 10,410 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Recent Acquisitions That Continue to Drive Growth and Value | LOUISVILLE, Ky., March 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or "BrightSpring Health Services") (NASDAQ: BTSG), a leading provider of home and community-based... ► Artikel lesen |